„iPS-Zellen ermöglichen personalisierte Medizin für ultraseltene Erkrankungen“
Crossref DOI link: https://doi.org/10.1007/s15005-026-4626-2
Published Online: 2026-01-23
Published Print: 2026-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Thomas
Text and Data Mining valid from 2026-01-01
Version of Record valid from 2026-01-01
Article History
First Online: 23 January 2026